ABSTRACT SUBMISSION 

  

SUBMISSION INFORMATION

We are pleased to announce that abstract submission for ISH2026 which will be held from 17th - 20th May 2026 at the Centara Grand and Bangkok Convention Centre at CentralWorld, Bangkok, Thailand. can now be submitted on our online system. In order to submit an abstract please sign up or, if you are already signed up, please login with your old credentials. Do not hesitate to use the password recovery function in case of need.

TIMELINE FOR ABSTRACT SUBMISSION
Date: Open Nows! Abstract submission begins
Date: January 31, 2026 Abstract Submission Closed
Date: March 15, 2026 Notifications of Acceptance (oral/e-poster)
Date: February 28, 2026 Deadline for Early Bird Registration
Date: April 30, 2026 Deadline for upload e-poster presentation

SUBMISSION GUIDELINES/FORMATTING

General Policies
The Scientific Committee of 40th Congress of The International Society of Hematology (ISH 2026) invites you to submit abstract(s) for oral and/or poster presentation.

  • Abstract should describe original, unpublished work and be submitted using the on-line.
  • Abstract will not be considered unless accompanied by the completed the Registration Form and fee.
  • Abstracts must be written in English only.
  • Author will be notified of the status of their submission, together with information on the presentation date and time by March 15, 2026
  • All accepted abstracts will be published in exactly the same as the condition submitted by authors.

Abstract Content
Abstract should include the reason or objective for the study, the method used, the findings and results, and the conclusion. Tables are not to be used.

Abstract format

  • Abstract submissions will only be accepted on the website. Please use the following instructions for abstract submission format
  • Complete the attached Abstract Submission Form
  • Type the abstract title in the TITLE box
  • Type the author and co-author names, institution or organization, in the AUTHORS box. Do not include degree and professional designations (i.e. Prof., Ph.D., MD. etc.). Institutional affiliations should be indicated clearly.
  • The name of the presenting author should appear first, and should be underline.
  • Type the abstract in the BODY TEXT box. Maximum 350 words.
  • Begin body text without indenting. Text must be single-spaced and justified at the left margin. Indent
  • subsequent paragraphs, and do not blank lines between them.

Subject areas

  • Bleeding disorders
  • Thrombosis
  • Bone marrow failure
  • Lymphoid malignancies
  • Plasma cell disorders
  • Myeloid malignancies
  • Cellular & Gene therapy
  • Hematopoietic stem cell transplantation
  • Pediatric hematology/oncology
  • Platelet disorders
  • Thalassemia
  • Red cell disorders
  • Transfusion Medicine
  • Laboratory Hematology
  • Supportive Care